Brief: Intelgenx Enters Animal Health Market By Signing Feasibility Agreement For Vetafilm Platform
Jan 9 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX ENTERS ANIMAL HEALTH MARKET BY SIGNING
FEASIBILITY
AGREEMENT FOR VETAFILM™ PLATFORM
* INTELGENX TECHNOLOGIES - WILL CONDUCT A FEASIBILITY STUDY
ON
UNDISCLOSED MOLECULE FOR BUCCAL ABSORPTION USING CO'S
PROPRIETARY VETAFILM PLATFORM
* INTELGENX TECHNOLOGIES CORP - WILL HAVE EXCLUSIVE RIGHTS
TO
FURTHER DEVELOP, MANUFACTURE AND SUPPLY DEVELOPED PRODUCT TO
PARTNER
Source text for Eikon: ID:nGNXbLy4Yx
Further company coverage: IGX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA